Parkinson’s disease, a progressive neurodegenerative disorder, is considered a multi-factorial disease influenced by genetic factors, comorbidities, and environmental exposures such as air pollution and chemicals used in manufacturing and agriculture.1 Understanding geographic patterns of Parkinson’s diagnoses can offer important clues about potential environmental contributions and regional differences.
We studied more than 46 million adult patients across 49 U.S. states who had at least three outpatient visits between 2020 and 2025 to better understand patterns of Parkinson’s diagnoses. Data for Alaska were too sparse to conduct a meaningful analysis. We first examined the unadjusted incidence rates for each state and then calculated an adjusted rate that accounted for age, sex, and comorbidities.
When looking at unadjusted incidence rates, we found that Nebraska (620 per 100,000 patients) and Kansas (596 per 100,000 patients) had the highest rates of newly diagnosed Parkinson’s disease during the study period. States with the lowest observed rates were Montana (264 per 100,000 patients) and Nevada (275 per 100,000 patients).
After adjusting for patient age, time in the study, sex, race, ethnicity, and comorbidities, a relative rate was established for each state compared to Minnesota, the median for overall rates. Nebraska and Kansas remained the highest with 561 diagnoses per 100,000 patients and 517 diagnoses per 100,000 patients, respectively. Utah had the third highest rate at 493 diagnosed per 100,000 patients. States with the lowest relative rates were Montana (308 per 100,000 patients), Wisconsin (329 per 100,000 patients), and Washington (339 per 100,000 patients).